logo
Why using the same arm for vaccines might boost the body's response

Why using the same arm for vaccines might boost the body's response

Yahoo28-04-2025

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting a booster in the same arm as the initial shot can boost the immune system's response. Now, we're getting clues as to why using the same arm for initial and booster doses might be better for activating the immune system's response to a vaccine.
In a small study published April 28 in the journal Cell, researchers from Australia found that when a vaccine is given, specialized immune cells called macrophages prepare to fight inside lymph nodes. The macrophages then direct where memory B cells go to more effectively respond to the booster when it is given in the same arm.
According to the team, the findings were made in mice and validated in human participants and offer enough evidence to refine how we approach vaccines.
'A unique and elegant aspect of this study is the team's ability to understand the rapid generation of effective vaccine responses,' Anthony Kelleher, a study co-author and clinician scientist at the Garvan Institute of Medical Research and the Kirby Institute at University of New South Wales Sydney, said in a statement. 'We did this by dissecting the complex biology in mice and then showed similar findings in humans. All this was done at the site of the generation of the vaccine response, the lymph node.'
[ Related: New study: US could see millions of measles cases if vaccination rates keep dropping. ]
During immunization, a harmless version of a pathogen called a vaccine antigen is introduced into the body. The antigen is then filtered through the lymph nodes. These work like immune system boot camps that train the body to fight off the real pathogen when and if they are confronted with it.
Previously, the team from the study looked at memory B cells. These cells are crucial for generating antibody responses when infections return. They found that memory B cells tend to stay on the lymph node closest to the injection site. They migrate to the outer layer of the local lymph node and interact closely with the macrophages–those specialized immune cells primed for battle in the lymph nodes–that reside there. When a booster was given in the same location, those already-on-alert macrophages captured the antigen and activated the memory B cells more efficiently. In turn, this made high quality antibodies.
'Macrophages are known to gobble up pathogens and clear away dead cells, but our research suggests the ones in the lymph nodes closest to the injection site also play a central role in orchestrating an effective vaccine response the next time around. So location does matter,' study co-author and immunologist Rama Dhenni said in a statement.
In this new study, the team conducted a clinical study with 30 volunteers receiving the Pfizer-BioNTech COVID-19 mRNA vaccine. Ten of the participants received their booster dose in the same arm as their first dose. The other 10 were given the second shot in the opposite arm.
According to the results, the group who received both doses in the same arm began producing neutralizing antibodies against the virus within the first week after the second dose. They also showed to be more effective against the potent Delta and Omicron COVID-19 variants. After four weeks, both groups had similar antibody levels. However, that early protection could be important during an outbreak.
'If you've had your COVID jabs in different arms, don't worry – our research shows that over time the difference in protection diminishes,' study co-author and immunologist Mee Ling Munier said in a statement. 'But during a pandemic, those first weeks of protection could make an enormous difference at a population level. The same-arm strategy could help achieve herd immunity faster – particularly important for rapidly mutating viruses where speed of response matters.'
It's important to note that this study included a small sample size and other studies have found benefits in switching arms. In future research, the team hopes to build on this work to refine vaccination guidelines and enhance the effectiveness of vaccines.
'If we can understand how to replicate or enhance the interactions between memory B cells and these macrophages, we may be able to design next-generation vaccines that require fewer boosters,' Tri Phan, a study co-author and clinical immunologist, said in a statement. 'This is a fundamental discovery in how the immune system organises itself to respond better to external threats – nature has come up with this brilliant system and we're just now beginning to understand it.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Arkansas ranks 45th for child well-being in national report, despite modest gains
Arkansas ranks 45th for child well-being in national report, despite modest gains

Yahoo

time17 minutes ago

  • Yahoo

Arkansas ranks 45th for child well-being in national report, despite modest gains

LITTLE ROCK, Ark. – Arkansas ranks 45th in the nation for overall child well-being, according to the 2025 KIDS COUNT Data Book released Monday by the Annie E. Casey Foundation. The annual report evaluates how children are doing across all 50 states in four areas: economic well-being, education, health, and family and community. 6-year-old Dennis Martin still missing after disappearing in Smokies in 1969 Though Arkansas has made some gains since the COVID-19 pandemic, the state continues to fall behind on most indicators compared to national averages. One area of progress is child poverty. The number of Arkansas children living in poverty has dropped by 7,000 since 2019. Still, 21% of the state's children remain in poverty, which is higher than the national rate of 16%. 'This report shows that while there has been some improvement, too many of our children are still being left behind,' said Keesa Smith-Brantley, executive director of Arkansas Advocates for Children and Families. 'We can't be satisfied with small gains when the overall trends remain troubling.' Racial disparities remain a serious issue. Officials said Black children in Arkansas face a poverty rate of 43%. Children of two or more races have a poverty rate of 21%, while 19% of Hispanic or Latino children live in poverty. Non-Hispanic White children have the lowest poverty rate at 15%. Ohio girl with brain injury from flu complications returns home In addition to being ranked 44th for child poverty, Arkansas is in the bottom 10 states on the following indicators: Teens ages 16-19 not attending school and not working 8th graders below proficient on math level Low-birthweight babies Child and teen deaths Teens ages 10-17 who are overweight or obese Children in single-parent families Children living in high-poverty areas Teen birth rate 'If you look at the data, teens are where we're falling further behind,' Smith-Brantley said. 'We're seeing more teens out of school and unemployed, and more who are overweight or obese. These are outcomes tied directly to the decisions our leaders are or aren't making.' For more information, visit Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

No drug price pledges in talks with US government, Pfizer CEO says
No drug price pledges in talks with US government, Pfizer CEO says

Yahoo

timean hour ago

  • Yahoo

No drug price pledges in talks with US government, Pfizer CEO says

STORY: Pfizer CEO Albert Bourla said Monday that he and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made. He made the comments at a Goldman Sachs healthcare conference. Last month President Trump issued an executive order directing drugmakers to lower the prices of their medicines to align with what other countries pay. According to the order, the administration was to set "Most Favored Nation" price targets within 30 days. The Department of Health and Human Services has said it expects drugmakers in the U.S. to set prices for their products at the lowest price paid by other high-income countries. Bourla said he didn't know what the companies would hear in 30 days and added the meetings with the administration so far were cordial but (quote) "not digging into the substance." It is unclear what mechanism the U.S. government will use to lower drug prices - analysts and legal experts have said the policy will be difficult to implement. Bourla said he is hopeful that, given U.S. pressure on European countries to pay more, prices there could increase. He said that if the U.S. resorts to price controls, Pfizer could consider not making drugs available for government reimbursement in some countries if prices don't increase there. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Healing Shingles Naturally: How East Meets West in Fighting Viral Pain and Brain Risk
Healing Shingles Naturally: How East Meets West in Fighting Viral Pain and Brain Risk

Epoch Times

time2 hours ago

  • Epoch Times

Healing Shingles Naturally: How East Meets West in Fighting Viral Pain and Brain Risk

Shingles, also known as herpes zoster, is a viral infection that causes a painful, blistering rash and often affects older adults or those with weakened immune systems. But since the COVID-19 pandemic, shingles has been appearing in unexpected age groups—raising new concerns about immunity, stress, and long-term health risks. Without timely treatment, this condition can lead to serious complications, including persistent nerve pain and even cognitive decline. In an episode of the 'Health 1+1' program, Jonathan Liu, a Canadian professor of Traditional Chinese Medicine, discussed both Western and TCM approaches to treating the infection, along with immune-boosting medicinal recipes that may help reduce the risk of shingles. The Importance of Early Treatment The primary treatment for shingles involves antiviral medications such as famciclovir or valacyclovir, which are typically taken orally. In more severe cases, intravenous acyclovir may be used, particularly in hospitalized or immunocompromised patients. Liu emphasized that early intervention is crucial. Ideally, antiviral therapy should begin before blisters appear. The medication works by suppressing viral replication rather than repairing tissue damage; therefore, starting treatment more than three days after the onset of blisters may significantly reduce their effectiveness.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store